NCT06558032 - Bioequivalence Study of Tamsulosin 0.4 mg Sustained Release Film-coated Tablets | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 6, 2023

Primary Completion Date

December 16, 2023

Study Completion Date

February 7, 2024

Conditions

Healthy

Interventions

DRUG

Tamsulosin 0.4 mg Sustained Release Tablet (produced by PT Dexa Medica, Indonesia)

One tablet of the test drug was given orally under fasting condition

DRUG

Harnal® OCAS 0.4 mg Prolonged Release Tablet (produced by Astellas Pharma Europe B.V., The Netherlands, imported by PT Combiphar, Indonesia)

One tablet of the test drug was given orally under fasting condition

Trial Locations (1)

PT Equilab International, Jakarta